Latest News and Press Releases

MIAMI, Dec. 07, 2016 (GLOBE NEWSWIRE) -- The Female Health Company/Veru Healthcare (NASDAQ:FHCO) today announced its plan for a Phase 2 clinical trial for MSS-722, the company’s proprietary oral...

MIAMI, Dec. 01, 2016 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) today announced that the company will present at the LD MICRO IX Annual “Main Event” Investor...

MIAMI, Nov. 30, 2016 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) today announced that, through its exclusive distributor in Brazil, Semina Indústria e Comércio...

MIAMI, Nov. 29, 2016 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) (FHC) today announced that it has completed an amendment to its existing $10 million revolving...

MIAMI, Nov. 17, 2016 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) today announced top line interim analysis of an independent, double-blind, randomized, controlled...

--Company Names Shiao Zhu as Vice President of Marketing for Veru Healthcare-- MIAMI, Nov. 16, 2016 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) today announced...

MIAMI, Nov. 15, 2016 (GLOBE NEWSWIRE) -- The Female Health Company / Veru Healthcare (NASDAQ:FHCO) today announced that it has strengthened its management team with the promotion of Denise van...

CHICAGO, Nov. 11, 2016 (GLOBE NEWSWIRE) -- The Female Health Company/Veru Healthcare (NASDAQ:FHCO) today announced that it has accepted an invitation from the U.S. Food and Drug Administration...

--Merger Combines FHC’s Existing FC2 Product with APP’s Deep Drug Development Product Portfolio that Addresses Multi-Billion Dollar Industry Segments-- CHICAGO and NEW YORK, Oct. 31, 2016 (GLOBE...

CHICAGO, Oct. 14, 2016 (GLOBE NEWSWIRE) -- The Female Health Company (FHC) (NASDAQ:FHCO) today announced that the Special Meeting of Shareholders scheduled for today to vote on three proposals...